"Skin Test for Parkinson's: A Breakthrough in Disease Detection"

A skin biopsy test called Syn-One has shown promise in detecting alpha-synuclein clumps, a hallmark feature of Parkinson's disease and related conditions, with positive results in over 90% of patients in a recent NIH-sponsored clinical trial. The test, developed by CND Life Sciences, offers a less invasive and more convenient diagnostic pathway compared to traditional methods, such as spinal taps. The study's findings suggest that the Syn-One Test could be a valuable tool for early disease diagnosis and may aid in improving care for patients with synucleinopathies.